AIMEDBIO
PR
ENG
KOR
ABOUT US
Overview
Leadership
Corporate Governance
R&D
AimedBio’s Drug Development
P-ADC™
Pipeline
IR
Disclosure
Stock
Financial Information
PR
Notice
Press Release
Data Room
CAREERS
Our Culture
Recruitment Process
Job Opportunities
Press Release
36 posts
Title
Content
Search
01
2024.11
AimedBio Receives FDA IND Clearance for FGFR3-Targeting ADC AMB302
VIEW MORE
21
2024.07
AimedBio Secures USD 30 Million in Series B
VIEW MORE
13
2023.12
AMB302, FGFR3-Targeting ADC Selected for KDDF Program
VIEW MORE
13
2023.09
AimedBio Secures Equity Investment from Samsung Life Science Fund
VIEW MORE
06
2023.07
Selected for KDDF Grant for Allergy Drug Discovery Program
VIEW MORE
1
2
3
4
5
